Point72 Asia (Singapore) Pte. Ltd. Ikena Oncology, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 21,184 shares of IKNA stock, worth $29,022. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,184
Previous 22,146
4.34%
Holding current value
$29,022
Previous $38.3 Million
9.32%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding IKNA
# of Institutions
55Shares Held
31.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$6.87 Million1.36% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$5.6 Million2.87% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$5.49 Million0.25% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.59MShares$4.91 Million3.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$4.85 Million0.16% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $49.7M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...